Genomic Lesions Involved in Chronic Myeloid Leukemia Progression
- 31 August 2009
- journal article
- review article
- Published by Elsevier BV in Clinical Leukemia
- Vol. 3 (2), E3-E10
- https://doi.org/10.3816/clk.2009.n.008
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The molecular biology of chronic myeloid leukemiaBlood, 2000
- Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic StrategiesHematology, 2000
- Chronic Myelogenous Leukemia: Biology and TherapyAnnals of Internal Medicine, 1999
- The Biology of Chronic Myeloid LeukemiaThe New England Journal of Medicine, 1999
- Development of Acute Lymphoblastic Leukemia and Myeloproliferative Disorder in Transgenic Mice Expressing p210bcr/abl: A Novel Transgenic Model for Human Ph1-Positive LeukemiasBlood, 1998
- Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16‐year periodBritish Journal of Haematology, 1997
- The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment]Blood, 1996
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemiaNature, 1983
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973